Raredr

Sleepless Nights - Raising a Child with Sanfilippo disease

Dave Esposito
Published Online: February 17, 2017

 
 
 
Dave Esposito is the father of a daughter diagnosed with Sanfilippo syndrome, a rare lysosomal disorder that currently has no treatment or cure. 
 
As Dave explains in this interview, the behavioral and neurodegenerative aspects of this rare disease can be stressful for the family. 
 
Dave recently took a sabbatical from work to learn more about Sanfilippo and hopefully find a means to treat his daughter before it is too late.

What is Sanfilippo disease?

Children with Sanfilippo syndrome have inadequate levels of specific enzymes needed to metabolize heparan sulfate. This leads to a build up of heparan sulfate in lysosomes that in turn leads to progressive neural degeneration.
 
There are 4 types of Sanfilippo syndrome based on the specific enzyme that is affected.
 
Sanfilippo Type A: heparan N-sulfatase.
Sanfilippo Type B: alpha-N-acetylglucosaminidase.
Sanfilippo Type C: acetyl-CoAlpha-glucosaminide acetyltransferase.
Sanfilippo Type D: N-acetylglucosamine 6-sulfatase.
 
For more information, visit https://curesff.org/


Latest Articles
Dave Esposito, father of a child with Sanfilippo syndrome, wants the FDA and the pharmaceutical industry to know that their definition of a good outcome measure is different than a parent's definition.
Alexion announced it will stop developing SBC-103 for the treatment of Sanfilippo type B [mucopolysaccharidosis (MPS) IIIB].
A Phase 3b trial assessing agalsidase beta in pediatric Fabry disease male patients shows encouraging results.
A Phase II study testing savolitinib in locally advanced or metastatic pulmonary sarcomatoid carcinoma (PSC) has begun in China.
$vacMongoViewPlus$ $vAR$